Clinical Research Trials : Complications of Chronic Liver Disease

Complications of Chronic Liver Disease

Hepatocellular Carcinoma

1. Target: A 5-year longitudinal, observational study of The Natural History and Management of Patients with Hepatocellular Carcinoma

  • Status: Open
  • PI: Dr. Patricia Jones
  • Coordinator: Tiffannia Grant
  • Contact: (305) 243-4649 / t.grant11@med.miami.edu

2. EVA: 17261-00 – Qualitative Interviews in Patients with Hepatocellular Carcinoma (HCC): Identifying Relevant Items from the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

  • Status: Open
  • PI: Dr. Patricia Jones
  • Coordinator: Diane Sabogal
  • Contact: (305) 243-1501 / d.sabogal@med.miami.edu

Hepatorenal Syndrome Type 1

1. Mallinckrodt: MNK19013058- Randomized, placebo study to confirm efficacy & safety of Terlipressin in subjects with Hepatorenal Syndrome Type 1

  • Status: Open
  • PI: Dr. Kalyan Bhamidimarri
  • Coordinator: Andrea Elibero
  • Contact: (305) 243-6968 / axe375@med.miami.edu

Thrombocytopenia

1. Shionogi: Phase 3 Randomized, Double-blind, Placebo-controlled, Evaluate S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients with CLD Undergoing Elective, Invasive Procedures.

  • Status: Open
  • PI: Dr. Cynthia Levy
  • Coordinator: Diane Sabogal
  • Contact: (305) 243-1501 / d.sabogal@med.miami.edu